Cantex Pharmaceuticals, Inc. (Cantex)

Oncology Corporate Profile

HQ Location

1792 Bell Tower Lane
Weston, FL 33326

Company Description

Cantex Pharmaceuticals, Inc. is clinical stage biopharmaceutical company focused on developing and commercializing proprietary compounds that enhance the efficacy and safety of the treatment of cancer and blood disorders

Website: http://www.cantex.com

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
CX-01O-desulfated heparin intravenousAcute Myelogenous Leukemia (AML)II
CX-02O-desulfated heparin intravenousGlioblastoma Multiforme (GBM)II
CX-02O-desulfated heparin intravenousBreast cancerI
CX-01O-desulfated heparin intravenousMyelodysplastic Syndrome (MDS)I
CX-02O-desulfated heparin intravenousProstate cancerI

View additional information on product candidates here »

Source: http://www.cantex.com

Recent News Headlines

There are no news items to display